nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CYP3A4—Temozolomide—malignant glioma	0.0403	1	CbGbCtD
Boceprevir—CTSK—skull—malignant glioma	0.0296	0.143	CbGeAlD
Boceprevir—CMA1—blood vessel—malignant glioma	0.019	0.0921	CbGeAlD
Boceprevir—CTSL—embryo—malignant glioma	0.00971	0.047	CbGeAlD
Boceprevir—CTSL—retina—malignant glioma	0.00858	0.0415	CbGeAlD
Boceprevir—CTSL—telencephalon—malignant glioma	0.00789	0.0382	CbGeAlD
Boceprevir—CTSV—medulla oblongata—malignant glioma	0.00759	0.0367	CbGeAlD
Boceprevir—CTSV—midbrain—malignant glioma	0.00694	0.0336	CbGeAlD
Boceprevir—CTSV—spinal cord—malignant glioma	0.00677	0.0328	CbGeAlD
Boceprevir—CTSK—retina—malignant glioma	0.00646	0.0313	CbGeAlD
Boceprevir—CTSS—embryo—malignant glioma	0.00641	0.031	CbGeAlD
Boceprevir—Abnormal behaviour—Temozolomide—malignant glioma	0.00624	0.0215	CcSEcCtD
Boceprevir—CTSL—medulla oblongata—malignant glioma	0.0062	0.03	CbGeAlD
Boceprevir—CTSL—midbrain—malignant glioma	0.00567	0.0274	CbGeAlD
Boceprevir—CTSS—retina—malignant glioma	0.00566	0.0274	CbGeAlD
Boceprevir—Impaired healing—Carmustine—malignant glioma	0.00556	0.0192	CcSEcCtD
Boceprevir—CTSL—spinal cord—malignant glioma	0.00553	0.0268	CbGeAlD
Boceprevir—CTSV—central nervous system—malignant glioma	0.00549	0.0266	CbGeAlD
Boceprevir—CTSS—telencephalon—malignant glioma	0.00521	0.0252	CbGeAlD
Boceprevir—Tongue discolouration—Temozolomide—malignant glioma	0.00481	0.0166	CcSEcCtD
Boceprevir—Cerebral ischaemia—Temozolomide—malignant glioma	0.00481	0.0166	CcSEcCtD
Boceprevir—CTSK—medulla oblongata—malignant glioma	0.00467	0.0226	CbGeAlD
Boceprevir—Lymphopenia—Temozolomide—malignant glioma	0.00454	0.0157	CcSEcCtD
Boceprevir—CTSL—central nervous system—malignant glioma	0.00449	0.0217	CbGeAlD
Boceprevir—CTSL—cerebellum—malignant glioma	0.00438	0.0212	CbGeAlD
Boceprevir—CTSV—brain—malignant glioma	0.00436	0.0211	CbGeAlD
Boceprevir—CTSK—spinal cord—malignant glioma	0.00417	0.0202	CbGeAlD
Boceprevir—CTSS—medulla oblongata—malignant glioma	0.00409	0.0198	CbGeAlD
Boceprevir—Haemorrhoids—Temozolomide—malignant glioma	0.00395	0.0136	CcSEcCtD
Boceprevir—Deep vein thrombosis—Temozolomide—malignant glioma	0.00382	0.0132	CcSEcCtD
Boceprevir—Encephalopathy—Carmustine—malignant glioma	0.00375	0.0129	CcSEcCtD
Boceprevir—CTSS—midbrain—malignant glioma	0.00374	0.0181	CbGeAlD
Boceprevir—CTSS—spinal cord—malignant glioma	0.00365	0.0177	CbGeAlD
Boceprevir—Cyst—Carmustine—malignant glioma	0.0036	0.0124	CcSEcCtD
Boceprevir—Tooth disorder—Temozolomide—malignant glioma	0.00358	0.0124	CcSEcCtD
Boceprevir—Parosmia—Temozolomide—malignant glioma	0.00358	0.0124	CcSEcCtD
Boceprevir—CTSL—brain—malignant glioma	0.00356	0.0172	CbGeAlD
Boceprevir—Paranoia—Carmustine—malignant glioma	0.00353	0.0122	CcSEcCtD
Boceprevir—CTSK—central nervous system—malignant glioma	0.00338	0.0164	CbGeAlD
Boceprevir—CTSK—cerebellum—malignant glioma	0.0033	0.016	CbGeAlD
Boceprevir—Apathy—Temozolomide—malignant glioma	0.00325	0.0112	CcSEcCtD
Boceprevir—Flat affect—Temozolomide—malignant glioma	0.00323	0.0111	CcSEcCtD
Boceprevir—Menorrhagia—Temozolomide—malignant glioma	0.00314	0.0108	CcSEcCtD
Boceprevir—Otitis media—Temozolomide—malignant glioma	0.00299	0.0103	CcSEcCtD
Boceprevir—Memory impairment—Temozolomide—malignant glioma	0.00296	0.0102	CcSEcCtD
Boceprevir—Hyperaesthesia—Temozolomide—malignant glioma	0.00296	0.0102	CcSEcCtD
Boceprevir—CTSS—central nervous system—malignant glioma	0.00296	0.0143	CbGeAlD
Boceprevir—CTSS—cerebellum—malignant glioma	0.00289	0.014	CbGeAlD
Boceprevir—Endocrine disorder—Temozolomide—malignant glioma	0.0028	0.00968	CcSEcCtD
Boceprevir—Disturbance in attention—Temozolomide—malignant glioma	0.00268	0.00926	CcSEcCtD
Boceprevir—CTSK—brain—malignant glioma	0.00268	0.013	CbGeAlD
Boceprevir—Amenorrhoea—Temozolomide—malignant glioma	0.00265	0.00913	CcSEcCtD
Boceprevir—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00256	0.00882	CcSEcCtD
Boceprevir—Herpes simplex—Temozolomide—malignant glioma	0.00252	0.00871	CcSEcCtD
Boceprevir—Hearing impaired—Temozolomide—malignant glioma	0.00244	0.00843	CcSEcCtD
Boceprevir—Neck pain—Carmustine—malignant glioma	0.00243	0.0084	CcSEcCtD
Boceprevir—Pulmonary embolism—Carmustine—malignant glioma	0.00241	0.0083	CcSEcCtD
Boceprevir—Injection site reaction—Carmustine—malignant glioma	0.00239	0.00825	CcSEcCtD
Boceprevir—Respiratory failure—Temozolomide—malignant glioma	0.00237	0.00817	CcSEcCtD
Boceprevir—Musculoskeletal pain—Temozolomide—malignant glioma	0.00235	0.00812	CcSEcCtD
Boceprevir—CTSS—brain—malignant glioma	0.00235	0.0114	CbGeAlD
Boceprevir—Pulmonary embolism—Temozolomide—malignant glioma	0.00232	0.00802	CcSEcCtD
Boceprevir—Candida infection—Carmustine—malignant glioma	0.0023	0.00793	CcSEcCtD
Boceprevir—Influenza like illness—Temozolomide—malignant glioma	0.00226	0.00779	CcSEcCtD
Boceprevir—Candida infection—Temozolomide—malignant glioma	0.00222	0.00766	CcSEcCtD
Boceprevir—Neoplasm—Carmustine—malignant glioma	0.00218	0.00751	CcSEcCtD
Boceprevir—Dry eye—Temozolomide—malignant glioma	0.00215	0.00741	CcSEcCtD
Boceprevir—Neoplasm—Temozolomide—malignant glioma	0.0021	0.00725	CcSEcCtD
Boceprevir—Mental disability—Carmustine—malignant glioma	0.00209	0.0072	CcSEcCtD
Boceprevir—Sepsis—Carmustine—malignant glioma	0.00209	0.0072	CcSEcCtD
Boceprevir—Mental disability—Temozolomide—malignant glioma	0.00202	0.00696	CcSEcCtD
Boceprevir—Diabetes mellitus—Carmustine—malignant glioma	0.00201	0.00693	CcSEcCtD
Boceprevir—Eye pain—Carmustine—malignant glioma	0.00193	0.00668	CcSEcCtD
Boceprevir—Gastroenteritis—Temozolomide—malignant glioma	0.0019	0.00657	CcSEcCtD
Boceprevir—ABCB1—blood vessel—malignant glioma	0.00189	0.00917	CbGeAlD
Boceprevir—Deafness—Temozolomide—malignant glioma	0.00189	0.00651	CcSEcCtD
Boceprevir—Eye pain—Temozolomide—malignant glioma	0.00187	0.00645	CcSEcCtD
Boceprevir—Amnesia—Carmustine—malignant glioma	0.00186	0.00641	CcSEcCtD
Boceprevir—Nasal congestion—Temozolomide—malignant glioma	0.00185	0.00639	CcSEcCtD
Boceprevir—Amnesia—Temozolomide—malignant glioma	0.0018	0.0062	CcSEcCtD
Boceprevir—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00179	0.00617	CcSEcCtD
Boceprevir—Affect lability—Temozolomide—malignant glioma	0.00166	0.00573	CcSEcCtD
Boceprevir—Mood swings—Temozolomide—malignant glioma	0.0016	0.00552	CcSEcCtD
Boceprevir—Hypokalaemia—Carmustine—malignant glioma	0.00159	0.00548	CcSEcCtD
Boceprevir—Dehydration—Temozolomide—malignant glioma	0.00157	0.00542	CcSEcCtD
Boceprevir—Dry skin—Temozolomide—malignant glioma	0.00155	0.00534	CcSEcCtD
Boceprevir—Muscular weakness—Carmustine—malignant glioma	0.00154	0.00531	CcSEcCtD
Boceprevir—Hypokalaemia—Temozolomide—malignant glioma	0.00154	0.0053	CcSEcCtD
Boceprevir—Breast disorder—Temozolomide—malignant glioma	0.00153	0.00526	CcSEcCtD
Boceprevir—Dysphagia—Carmustine—malignant glioma	0.00151	0.00521	CcSEcCtD
Boceprevir—Muscular weakness—Temozolomide—malignant glioma	0.00149	0.00514	CcSEcCtD
Boceprevir—Abdominal distension—Temozolomide—malignant glioma	0.00147	0.00507	CcSEcCtD
Boceprevir—Dysphagia—Temozolomide—malignant glioma	0.00146	0.00503	CcSEcCtD
Boceprevir—Pancytopenia—Carmustine—malignant glioma	0.00143	0.00495	CcSEcCtD
Boceprevir—Neutropenia—Carmustine—malignant glioma	0.00141	0.00487	CcSEcCtD
Boceprevir—Bronchitis—Temozolomide—malignant glioma	0.0014	0.00484	CcSEcCtD
Boceprevir—Pancytopenia—Temozolomide—malignant glioma	0.00139	0.00478	CcSEcCtD
Boceprevir—Dysuria—Temozolomide—malignant glioma	0.00136	0.00471	CcSEcCtD
Boceprevir—Neutropenia—Temozolomide—malignant glioma	0.00136	0.00471	CcSEcCtD
Boceprevir—Hyperglycaemia—Carmustine—malignant glioma	0.00136	0.0047	CcSEcCtD
Boceprevir—Pneumonia—Carmustine—malignant glioma	0.00135	0.00467	CcSEcCtD
Boceprevir—Pollakiuria—Temozolomide—malignant glioma	0.00135	0.00465	CcSEcCtD
Boceprevir—Erectile dysfunction—Temozolomide—malignant glioma	0.00134	0.00464	CcSEcCtD
Boceprevir—Depression—Carmustine—malignant glioma	0.00134	0.00463	CcSEcCtD
Boceprevir—Photosensitivity reaction—Temozolomide—malignant glioma	0.00133	0.00459	CcSEcCtD
Boceprevir—Weight decreased—Temozolomide—malignant glioma	0.00132	0.00455	CcSEcCtD
Boceprevir—Neuropathy peripheral—Carmustine—malignant glioma	0.00132	0.00455	CcSEcCtD
Boceprevir—Hyperglycaemia—Temozolomide—malignant glioma	0.00132	0.00454	CcSEcCtD
Boceprevir—Stomatitis—Carmustine—malignant glioma	0.00131	0.00453	CcSEcCtD
Boceprevir—Urinary tract infection—Carmustine—malignant glioma	0.00131	0.00451	CcSEcCtD
Boceprevir—Pneumonia—Temozolomide—malignant glioma	0.00131	0.00451	CcSEcCtD
Boceprevir—Infestation—Temozolomide—malignant glioma	0.0013	0.00449	CcSEcCtD
Boceprevir—Infestation NOS—Temozolomide—malignant glioma	0.0013	0.00449	CcSEcCtD
Boceprevir—Depression—Temozolomide—malignant glioma	0.0013	0.00447	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00129	0.00445	CcSEcCtD
Boceprevir—Neuropathy peripheral—Temozolomide—malignant glioma	0.00127	0.0044	CcSEcCtD
Boceprevir—Stomatitis—Temozolomide—malignant glioma	0.00127	0.00437	CcSEcCtD
Boceprevir—Urinary tract infection—Temozolomide—malignant glioma	0.00126	0.00436	CcSEcCtD
Boceprevir—Hepatobiliary disease—Temozolomide—malignant glioma	0.00123	0.00424	CcSEcCtD
Boceprevir—Sinusitis—Temozolomide—malignant glioma	0.00122	0.00421	CcSEcCtD
Boceprevir—Hypoaesthesia—Carmustine—malignant glioma	0.0012	0.00415	CcSEcCtD
Boceprevir—Oedema peripheral—Carmustine—malignant glioma	0.00119	0.00411	CcSEcCtD
Boceprevir—Connective tissue disorder—Carmustine—malignant glioma	0.00119	0.0041	CcSEcCtD
Boceprevir—Visual impairment—Carmustine—malignant glioma	0.00116	0.00402	CcSEcCtD
Boceprevir—Hypoaesthesia—Temozolomide—malignant glioma	0.00116	0.00401	CcSEcCtD
Boceprevir—Pharyngitis—Temozolomide—malignant glioma	0.00116	0.004	CcSEcCtD
Boceprevir—Urinary tract disorder—Temozolomide—malignant glioma	0.00115	0.00398	CcSEcCtD
Boceprevir—Oedema peripheral—Temozolomide—malignant glioma	0.00115	0.00397	CcSEcCtD
Boceprevir—Connective tissue disorder—Temozolomide—malignant glioma	0.00115	0.00396	CcSEcCtD
Boceprevir—Urethral disorder—Temozolomide—malignant glioma	0.00114	0.00395	CcSEcCtD
Boceprevir—ABCB1—embryo—malignant glioma	0.00113	0.00547	CbGeAlD
Boceprevir—Eye disorder—Carmustine—malignant glioma	0.00113	0.0039	CcSEcCtD
Boceprevir—Visual impairment—Temozolomide—malignant glioma	0.00113	0.00388	CcSEcCtD
Boceprevir—Flushing—Carmustine—malignant glioma	0.00112	0.00387	CcSEcCtD
Boceprevir—Erythema multiforme—Temozolomide—malignant glioma	0.0011	0.00381	CcSEcCtD
Boceprevir—Eye disorder—Temozolomide—malignant glioma	0.00109	0.00376	CcSEcCtD
Boceprevir—Tinnitus—Temozolomide—malignant glioma	0.00109	0.00376	CcSEcCtD
Boceprevir—Cardiac disorder—Temozolomide—malignant glioma	0.00108	0.00374	CcSEcCtD
Boceprevir—Flushing—Temozolomide—malignant glioma	0.00108	0.00374	CcSEcCtD
Boceprevir—Arrhythmia—Carmustine—malignant glioma	0.00108	0.00372	CcSEcCtD
Boceprevir—Alopecia—Carmustine—malignant glioma	0.00107	0.00368	CcSEcCtD
Boceprevir—Angiopathy—Temozolomide—malignant glioma	0.00106	0.00366	CcSEcCtD
Boceprevir—Mental disorder—Carmustine—malignant glioma	0.00106	0.00365	CcSEcCtD
Boceprevir—Immune system disorder—Temozolomide—malignant glioma	0.00105	0.00364	CcSEcCtD
Boceprevir—Mediastinal disorder—Temozolomide—malignant glioma	0.00105	0.00363	CcSEcCtD
Boceprevir—Erythema—Carmustine—malignant glioma	0.00105	0.00363	CcSEcCtD
Boceprevir—Malnutrition—Carmustine—malignant glioma	0.00105	0.00363	CcSEcCtD
Boceprevir—Chills—Temozolomide—malignant glioma	0.00105	0.00361	CcSEcCtD
Boceprevir—Alopecia—Temozolomide—malignant glioma	0.00103	0.00356	CcSEcCtD
Boceprevir—Mental disorder—Temozolomide—malignant glioma	0.00102	0.00353	CcSEcCtD
Boceprevir—Back pain—Carmustine—malignant glioma	0.00102	0.00351	CcSEcCtD
Boceprevir—Erythema—Temozolomide—malignant glioma	0.00102	0.00351	CcSEcCtD
Boceprevir—Malnutrition—Temozolomide—malignant glioma	0.00102	0.00351	CcSEcCtD
Boceprevir—ABCB1—retina—malignant glioma	0.000999	0.00484	CbGeAlD
Boceprevir—Dysgeusia—Temozolomide—malignant glioma	0.000995	0.00343	CcSEcCtD
Boceprevir—Vision blurred—Carmustine—malignant glioma	0.000991	0.00342	CcSEcCtD
Boceprevir—Back pain—Temozolomide—malignant glioma	0.000983	0.00339	CcSEcCtD
Boceprevir—Anaemia—Carmustine—malignant glioma	0.000972	0.00335	CcSEcCtD
Boceprevir—Agitation—Carmustine—malignant glioma	0.000966	0.00333	CcSEcCtD
Boceprevir—Vision blurred—Temozolomide—malignant glioma	0.000958	0.00331	CcSEcCtD
Boceprevir—Ill-defined disorder—Temozolomide—malignant glioma	0.000943	0.00325	CcSEcCtD
Boceprevir—Leukopenia—Carmustine—malignant glioma	0.000941	0.00325	CcSEcCtD
Boceprevir—Anaemia—Temozolomide—malignant glioma	0.000939	0.00324	CcSEcCtD
Boceprevir—Agitation—Temozolomide—malignant glioma	0.000934	0.00322	CcSEcCtD
Boceprevir—Angioedema—Temozolomide—malignant glioma	0.000929	0.0032	CcSEcCtD
Boceprevir—ABCB1—telencephalon—malignant glioma	0.000919	0.00445	CbGeAlD
Boceprevir—Malaise—Temozolomide—malignant glioma	0.000917	0.00316	CcSEcCtD
Boceprevir—Vertigo—Temozolomide—malignant glioma	0.000913	0.00315	CcSEcCtD
Boceprevir—Leukopenia—Temozolomide—malignant glioma	0.00091	0.00314	CcSEcCtD
Boceprevir—Hypertension—Carmustine—malignant glioma	0.000908	0.00313	CcSEcCtD
Boceprevir—Palpitations—Temozolomide—malignant glioma	0.000898	0.0031	CcSEcCtD
Boceprevir—Chest pain—Carmustine—malignant glioma	0.000895	0.00309	CcSEcCtD
Boceprevir—Myalgia—Carmustine—malignant glioma	0.000895	0.00309	CcSEcCtD
Boceprevir—Anxiety—Carmustine—malignant glioma	0.000892	0.00308	CcSEcCtD
Boceprevir—Cough—Temozolomide—malignant glioma	0.000887	0.00306	CcSEcCtD
Boceprevir—Hypertension—Temozolomide—malignant glioma	0.000877	0.00303	CcSEcCtD
Boceprevir—Confusional state—Carmustine—malignant glioma	0.000865	0.00299	CcSEcCtD
Boceprevir—Arthralgia—Temozolomide—malignant glioma	0.000865	0.00299	CcSEcCtD
Boceprevir—Myalgia—Temozolomide—malignant glioma	0.000865	0.00299	CcSEcCtD
Boceprevir—Anxiety—Temozolomide—malignant glioma	0.000862	0.00298	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000859	0.00297	CcSEcCtD
Boceprevir—Discomfort—Temozolomide—malignant glioma	0.000855	0.00295	CcSEcCtD
Boceprevir—Infection—Carmustine—malignant glioma	0.000853	0.00294	CcSEcCtD
Boceprevir—Dry mouth—Temozolomide—malignant glioma	0.000846	0.00292	CcSEcCtD
Boceprevir—Thrombocytopenia—Carmustine—malignant glioma	0.00084	0.0029	CcSEcCtD
Boceprevir—Tachycardia—Carmustine—malignant glioma	0.000838	0.00289	CcSEcCtD
Boceprevir—Confusional state—Temozolomide—malignant glioma	0.000836	0.00289	CcSEcCtD
Boceprevir—Infection—Temozolomide—malignant glioma	0.000824	0.00284	CcSEcCtD
Boceprevir—Nervous system disorder—Temozolomide—malignant glioma	0.000813	0.00281	CcSEcCtD
Boceprevir—Thrombocytopenia—Temozolomide—malignant glioma	0.000812	0.0028	CcSEcCtD
Boceprevir—Skin disorder—Temozolomide—malignant glioma	0.000806	0.00278	CcSEcCtD
Boceprevir—Hypotension—Carmustine—malignant glioma	0.000802	0.00277	CcSEcCtD
Boceprevir—Hyperhidrosis—Temozolomide—malignant glioma	0.000802	0.00277	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000782	0.0027	CcSEcCtD
Boceprevir—Insomnia—Carmustine—malignant glioma	0.000776	0.00268	CcSEcCtD
Boceprevir—Paraesthesia—Carmustine—malignant glioma	0.000771	0.00266	CcSEcCtD
Boceprevir—Dyspnoea—Carmustine—malignant glioma	0.000765	0.00264	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000756	0.00261	CcSEcCtD
Boceprevir—Insomnia—Temozolomide—malignant glioma	0.00075	0.00259	CcSEcCtD
Boceprevir—Decreased appetite—Carmustine—malignant glioma	0.000746	0.00257	CcSEcCtD
Boceprevir—Paraesthesia—Temozolomide—malignant glioma	0.000745	0.00257	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Carmustine—malignant glioma	0.000741	0.00256	CcSEcCtD
Boceprevir—Dyspnoea—Temozolomide—malignant glioma	0.000739	0.00255	CcSEcCtD
Boceprevir—CYP3A4—central nervous system—malignant glioma	0.000738	0.00357	CbGeAlD
Boceprevir—Constipation—Carmustine—malignant glioma	0.000734	0.00253	CcSEcCtD
Boceprevir—Pain—Carmustine—malignant glioma	0.000734	0.00253	CcSEcCtD
Boceprevir—Dyspepsia—Temozolomide—malignant glioma	0.00073	0.00252	CcSEcCtD
Boceprevir—ABCB1—medulla oblongata—malignant glioma	0.000722	0.0035	CbGeAlD
Boceprevir—Decreased appetite—Temozolomide—malignant glioma	0.000721	0.00249	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000716	0.00247	CcSEcCtD
Boceprevir—Fatigue—Temozolomide—malignant glioma	0.000715	0.00247	CcSEcCtD
Boceprevir—Pain—Temozolomide—malignant glioma	0.000709	0.00245	CcSEcCtD
Boceprevir—Constipation—Temozolomide—malignant glioma	0.000709	0.00245	CcSEcCtD
Boceprevir—Feeling abnormal—Carmustine—malignant glioma	0.000707	0.00244	CcSEcCtD
Boceprevir—Gastrointestinal pain—Carmustine—malignant glioma	0.000702	0.00242	CcSEcCtD
Boceprevir—Feeling abnormal—Temozolomide—malignant glioma	0.000684	0.00236	CcSEcCtD
Boceprevir—Abdominal pain—Carmustine—malignant glioma	0.000679	0.00234	CcSEcCtD
Boceprevir—Body temperature increased—Carmustine—malignant glioma	0.000679	0.00234	CcSEcCtD
Boceprevir—Gastrointestinal pain—Temozolomide—malignant glioma	0.000678	0.00234	CcSEcCtD
Boceprevir—ABCB1—midbrain—malignant glioma	0.00066	0.0032	CbGeAlD
Boceprevir—Urticaria—Temozolomide—malignant glioma	0.000659	0.00227	CcSEcCtD
Boceprevir—Body temperature increased—Temozolomide—malignant glioma	0.000656	0.00226	CcSEcCtD
Boceprevir—Abdominal pain—Temozolomide—malignant glioma	0.000656	0.00226	CcSEcCtD
Boceprevir—ABCB1—spinal cord—malignant glioma	0.000644	0.00312	CbGeAlD
Boceprevir—Hypersensitivity—Carmustine—malignant glioma	0.000632	0.00218	CcSEcCtD
Boceprevir—Asthenia—Carmustine—malignant glioma	0.000616	0.00213	CcSEcCtD
Boceprevir—Hypersensitivity—Temozolomide—malignant glioma	0.000611	0.00211	CcSEcCtD
Boceprevir—Asthenia—Temozolomide—malignant glioma	0.000595	0.00205	CcSEcCtD
Boceprevir—Diarrhoea—Carmustine—malignant glioma	0.000587	0.00203	CcSEcCtD
Boceprevir—Pruritus—Temozolomide—malignant glioma	0.000587	0.00203	CcSEcCtD
Boceprevir—Dizziness—Carmustine—malignant glioma	0.000568	0.00196	CcSEcCtD
Boceprevir—Diarrhoea—Temozolomide—malignant glioma	0.000568	0.00196	CcSEcCtD
Boceprevir—Dizziness—Temozolomide—malignant glioma	0.000548	0.00189	CcSEcCtD
Boceprevir—Vomiting—Carmustine—malignant glioma	0.000546	0.00188	CcSEcCtD
Boceprevir—Rash—Carmustine—malignant glioma	0.000541	0.00187	CcSEcCtD
Boceprevir—Dermatitis—Carmustine—malignant glioma	0.000541	0.00187	CcSEcCtD
Boceprevir—Headache—Carmustine—malignant glioma	0.000538	0.00186	CcSEcCtD
Boceprevir—Vomiting—Temozolomide—malignant glioma	0.000527	0.00182	CcSEcCtD
Boceprevir—Rash—Temozolomide—malignant glioma	0.000523	0.0018	CcSEcCtD
Boceprevir—ABCB1—central nervous system—malignant glioma	0.000523	0.00253	CbGeAlD
Boceprevir—Dermatitis—Temozolomide—malignant glioma	0.000522	0.0018	CcSEcCtD
Boceprevir—Headache—Temozolomide—malignant glioma	0.00052	0.00179	CcSEcCtD
Boceprevir—ABCB1—cerebellum—malignant glioma	0.000511	0.00247	CbGeAlD
Boceprevir—Nausea—Carmustine—malignant glioma	0.00051	0.00176	CcSEcCtD
Boceprevir—Nausea—Temozolomide—malignant glioma	0.000493	0.0017	CcSEcCtD
Boceprevir—ABCB1—brain—malignant glioma	0.000415	0.00201	CbGeAlD
Boceprevir—CTSL—Innate Immune System—PIK3CA—malignant glioma	0.000104	0.000225	CbGpPWpGaD
Boceprevir—CTSL—Immune System—BCL2—malignant glioma	0.000104	0.000224	CbGpPWpGaD
Boceprevir—CTSV—Immune System—BCL2—malignant glioma	0.000104	0.000224	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IFNG—malignant glioma	0.000103	0.000222	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IFNG—malignant glioma	0.000103	0.000222	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PDGFB—malignant glioma	0.000103	0.000221	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MDM2—malignant glioma	0.000102	0.000221	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MDM2—malignant glioma	0.000102	0.000221	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FGFR1—malignant glioma	0.000102	0.00022	CbGpPWpGaD
Boceprevir—CTSV—Immune System—RAF1—malignant glioma	0.000102	0.00022	CbGpPWpGaD
Boceprevir—CTSL—Immune System—RAF1—malignant glioma	0.000102	0.00022	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ERBB2—malignant glioma	0.000101	0.000218	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ERBB2—malignant glioma	0.000101	0.000218	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PTEN—malignant glioma	0.000101	0.000217	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PDGFRA—malignant glioma	0.000101	0.000217	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—PIK3CA—malignant glioma	0.0001	0.000216	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—PIK3CA—malignant glioma	0.0001	0.000216	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PIK3CB—malignant glioma	9.94e-05	0.000215	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PIK3CB—malignant glioma	9.94e-05	0.000215	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—EGFR—malignant glioma	9.94e-05	0.000215	CbGpPWpGaD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	9.92e-05	0.000214	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT2—malignant glioma	9.84e-05	0.000212	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—RTEL1—malignant glioma	9.78e-05	0.000211	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SPP1—malignant glioma	9.77e-05	0.000211	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IFNG—malignant glioma	9.74e-05	0.00021	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PTEN—malignant glioma	9.67e-05	0.000209	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	9.59e-05	0.000207	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—EGFR—malignant glioma	9.54e-05	0.000206	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PIK3CD—malignant glioma	9.45e-05	0.000204	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—KRAS—malignant glioma	9.39e-05	0.000203	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	9.35e-05	0.000202	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	9.33e-05	0.000201	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TERT—malignant glioma	9.26e-05	0.0002	CbGpPWpGaD
Boceprevir—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	9.2e-05	0.000199	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL1B—malignant glioma	9.17e-05	0.000198	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL1B—malignant glioma	9.17e-05	0.000198	CbGpPWpGaD
Boceprevir—CTSS—Immune System—BAD—malignant glioma	9.14e-05	0.000197	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL2—malignant glioma	9.13e-05	0.000197	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL2—malignant glioma	9.13e-05	0.000197	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CXCL8—malignant glioma	9.06e-05	0.000195	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FGF2—malignant glioma	9.05e-05	0.000195	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PDGFB—malignant glioma	9.04e-05	0.000195	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—KRAS—malignant glioma	9.01e-05	0.000195	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGFR1—malignant glioma	8.99e-05	0.000194	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD80—malignant glioma	8.87e-05	0.000192	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HIF1A—malignant glioma	8.85e-05	0.000191	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGF—malignant glioma	8.75e-05	0.000189	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PTPN11—malignant glioma	8.7e-05	0.000188	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	8.69e-05	0.000188	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL1B—malignant glioma	8.69e-05	0.000188	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CASP3—malignant glioma	8.67e-05	0.000187	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL2—malignant glioma	8.65e-05	0.000187	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PIK3CA—malignant glioma	8.62e-05	0.000186	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	8.62e-05	0.000186	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTT1—malignant glioma	8.6e-05	0.000186	CbGpPWpGaD
Boceprevir—CTSK—Immune System—BCL2—malignant glioma	8.6e-05	0.000186	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PTEN—malignant glioma	8.59e-05	0.000186	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PTEN—malignant glioma	8.59e-05	0.000186	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CAV1—malignant glioma	8.56e-05	0.000185	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IFNG—malignant glioma	8.52e-05	0.000184	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—AKT1—malignant glioma	8.5e-05	0.000184	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—AKT1—malignant glioma	8.5e-05	0.000184	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	8.49e-05	0.000183	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MDM2—malignant glioma	8.47e-05	0.000183	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KDR—malignant glioma	8.47e-05	0.000183	CbGpPWpGaD
Boceprevir—CTSK—Immune System—RAF1—malignant glioma	8.44e-05	0.000182	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ERBB2—malignant glioma	8.35e-05	0.00018	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—PIK3CA—malignant glioma	8.28e-05	0.000179	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PIK3CB—malignant glioma	8.24e-05	0.000178	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—EGFR—malignant glioma	8.18e-05	0.000177	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—AKT1—malignant glioma	8.17e-05	0.000176	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—AKT1—malignant glioma	8.17e-05	0.000176	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—F2—malignant glioma	8.15e-05	0.000176	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FN1—malignant glioma	8.15e-05	0.000176	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT2—malignant glioma	8.1e-05	0.000175	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—PTGS1—malignant glioma	8.06e-05	0.000174	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—BAD—malignant glioma	8.05e-05	0.000174	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NOTCH1—malignant glioma	7.98e-05	0.000172	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—EGFR—malignant glioma	7.86e-05	0.00017	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	7.83e-05	0.000169	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CD80—malignant glioma	7.82e-05	0.000169	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—APC—malignant glioma	7.8e-05	0.000168	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CG—malignant glioma	7.8e-05	0.000168	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CD—malignant glioma	7.79e-05	0.000168	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—KRAS—malignant glioma	7.73e-05	0.000167	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGF—malignant glioma	7.71e-05	0.000166	CbGpPWpGaD
Boceprevir—CTSL—Immune System—STAT3—malignant glioma	7.69e-05	0.000166	CbGpPWpGaD
Boceprevir—CTSV—Immune System—STAT3—malignant glioma	7.69e-05	0.000166	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTPN11—malignant glioma	7.66e-05	0.000165	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL1B—malignant glioma	7.6e-05	0.000164	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL2—malignant glioma	7.57e-05	0.000163	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FGF2—malignant glioma	7.45e-05	0.000161	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—COX8A—malignant glioma	7.44e-05	0.000161	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—KRAS—malignant glioma	7.42e-05	0.00016	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—malignant glioma	7.36e-05	0.000159	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—BRAF—malignant glioma	7.33e-05	0.000158	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT2—malignant glioma	7.14e-05	0.000154	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PTEN—malignant glioma	7.12e-05	0.000154	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PIK3CA—malignant glioma	7.1e-05	0.000153	CbGpPWpGaD
Boceprevir—CTSS—Immune System—BCL2—malignant glioma	7.08e-05	0.000153	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—AKT1—malignant glioma	7.05e-05	0.000152	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IFNG—malignant glioma	7.01e-05	0.000151	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	6.99e-05	0.000151	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EGFR—malignant glioma	6.99e-05	0.000151	CbGpPWpGaD
Boceprevir—CTSL—Immune System—EGFR—malignant glioma	6.99e-05	0.000151	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MDM2—malignant glioma	6.97e-05	0.000151	CbGpPWpGaD
Boceprevir—CTSS—Immune System—RAF1—malignant glioma	6.95e-05	0.00015	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ERBB2—malignant glioma	6.88e-05	0.000148	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CD—malignant glioma	6.86e-05	0.000148	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PIK3CA—malignant glioma	6.82e-05	0.000147	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CB—malignant glioma	6.79e-05	0.000146	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—AKT1—malignant glioma	6.77e-05	0.000146	CbGpPWpGaD
Boceprevir—CTSV—Immune System—KRAS—malignant glioma	6.6e-05	0.000142	CbGpPWpGaD
Boceprevir—CTSL—Immune System—KRAS—malignant glioma	6.6e-05	0.000142	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGF2—malignant glioma	6.57e-05	0.000142	CbGpPWpGaD
Boceprevir—CTSK—Immune System—STAT3—malignant glioma	6.37e-05	0.000137	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ASMT—malignant glioma	6.33e-05	0.000137	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—malignant glioma	6.3e-05	0.000136	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	6.27e-05	0.000135	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL1B—malignant glioma	6.26e-05	0.000135	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL2—malignant glioma	6.23e-05	0.000135	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MDM2—malignant glioma	6.14e-05	0.000133	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RAF1—malignant glioma	6.12e-05	0.000132	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	6.07e-05	0.000131	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PIK3CA—malignant glioma	6.06e-05	0.000131	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PIK3CA—malignant glioma	6.06e-05	0.000131	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ERBB2—malignant glioma	6.06e-05	0.000131	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—RTEL1—malignant glioma	6.03e-05	0.00013	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	6e-05	0.00013	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CB—malignant glioma	5.98e-05	0.000129	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTP1—malignant glioma	5.96e-05	0.000129	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—BCAN—malignant glioma	5.95e-05	0.000128	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	5.88e-05	0.000127	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PTEN—malignant glioma	5.86e-05	0.000127	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—AKT1—malignant glioma	5.8e-05	0.000125	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EGFR—malignant glioma	5.79e-05	0.000125	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCL8—malignant glioma	5.74e-05	0.000124	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—COX8A—malignant glioma	5.62e-05	0.000121	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—AKT1—malignant glioma	5.57e-05	0.00012	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CASP3—malignant glioma	5.5e-05	0.000119	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL2—malignant glioma	5.49e-05	0.000119	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KRAS—malignant glioma	5.47e-05	0.000118	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	5.42e-05	0.000117	CbGpPWpGaD
Boceprevir—CTSS—Immune System—STAT3—malignant glioma	5.24e-05	0.000113	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP9—malignant glioma	5.2e-05	0.000112	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTEN—malignant glioma	5.17e-05	0.000112	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	5.11e-05	0.00011	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PIK3CA—malignant glioma	5.02e-05	0.000108	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AKT1—malignant glioma	4.95e-05	0.000107	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AKT1—malignant glioma	4.95e-05	0.000107	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	4.85e-05	0.000105	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—IDH2—malignant glioma	4.8e-05	0.000104	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	4.78e-05	0.000103	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ASMT—malignant glioma	4.78e-05	0.000103	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	4.77e-05	0.000103	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGFR—malignant glioma	4.77e-05	0.000103	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	4.76e-05	0.000103	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	4.71e-05	0.000102	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—malignant glioma	4.67e-05	0.000101	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—STAT3—malignant glioma	4.62e-05	9.97e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	4.61e-05	9.95e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2B6—malignant glioma	4.51e-05	9.74e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—KRAS—malignant glioma	4.5e-05	9.72e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—BCAN—malignant glioma	4.49e-05	9.69e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	4.38e-05	9.46e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MYC—malignant glioma	4.29e-05	9.27e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	4.28e-05	9.23e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGFR—malignant glioma	4.2e-05	9.06e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	4.17e-05	9.01e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CA—malignant glioma	4.14e-05	8.93e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—IDH1—malignant glioma	4.12e-05	8.9e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—malignant glioma	4.1e-05	8.86e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	4.02e-05	8.67e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SPHK1—malignant glioma	3.99e-05	8.62e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KRAS—malignant glioma	3.97e-05	8.56e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2C18—malignant glioma	3.91e-05	8.44e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CA—malignant glioma	3.64e-05	7.87e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	3.63e-05	7.84e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—IDH2—malignant glioma	3.62e-05	7.81e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—malignant glioma	3.53e-05	7.61e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—COX8A—malignant glioma	3.46e-05	7.47e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2B6—malignant glioma	3.4e-05	7.35e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—malignant glioma	3.38e-05	7.3e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.34e-05	7.21e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.27e-05	7.05e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTT1—malignant glioma	3.16e-05	6.83e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—IDH1—malignant glioma	3.11e-05	6.72e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.11e-05	6.72e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.09e-05	6.66e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SPHK1—malignant glioma	3.01e-05	6.5e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—malignant glioma	2.98e-05	6.43e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS1—malignant glioma	2.96e-05	6.4e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2C18—malignant glioma	2.95e-05	6.37e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ASMT—malignant glioma	2.94e-05	6.35e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.83e-05	6.12e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—BCAN—malignant glioma	2.77e-05	5.97e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—BCHE—malignant glioma	2.75e-05	5.95e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.74e-05	5.92e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC5A5—malignant glioma	2.72e-05	5.87e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTT1—malignant glioma	2.39e-05	5.15e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.32e-05	5e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS1—malignant glioma	2.24e-05	4.83e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—IDH2—malignant glioma	2.23e-05	4.81e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTP1—malignant glioma	2.19e-05	4.73e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CAT—malignant glioma	2.13e-05	4.6e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.1e-05	4.53e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—BCHE—malignant glioma	2.08e-05	4.49e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC5A5—malignant glioma	2.05e-05	4.43e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NCOR1—malignant glioma	2.01e-05	4.35e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—IDH1—malignant glioma	1.92e-05	4.14e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.89e-05	4.08e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SPHK1—malignant glioma	1.86e-05	4.01e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.82e-05	3.92e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTP1—malignant glioma	1.65e-05	3.57e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CAV1—malignant glioma	1.64e-05	3.54e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CAT—malignant glioma	1.61e-05	3.47e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NCOR1—malignant glioma	1.52e-05	3.28e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CG—malignant glioma	1.5e-05	3.23e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTT1—malignant glioma	1.47e-05	3.17e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARG—malignant glioma	1.44e-05	3.12e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS1—malignant glioma	1.38e-05	2.97e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CD—malignant glioma	1.31e-05	2.84e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—BCHE—malignant glioma	1.28e-05	2.76e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.27e-05	2.73e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CAV1—malignant glioma	1.24e-05	2.67e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.15e-05	2.47e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—malignant glioma	1.14e-05	2.45e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CG—malignant glioma	1.13e-05	2.44e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARG—malignant glioma	1.09e-05	2.35e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTP1—malignant glioma	1.02e-05	2.2e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CD—malignant glioma	9.92e-06	2.14e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CAT—malignant glioma	9.92e-06	2.14e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTEN—malignant glioma	9.9e-06	2.14e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NCOR1—malignant glioma	9.36e-06	2.02e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CB—malignant glioma	8.65e-06	1.87e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—malignant glioma	8.57e-06	1.85e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CAV1—malignant glioma	7.63e-06	1.65e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTEN—malignant glioma	7.47e-06	1.61e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CA—malignant glioma	6.99e-06	1.51e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CG—malignant glioma	6.95e-06	1.5e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARG—malignant glioma	6.71e-06	1.45e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CD—malignant glioma	6.11e-06	1.32e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—malignant glioma	5.71e-06	1.23e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CB—malignant glioma	5.33e-06	1.15e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—malignant glioma	5.28e-06	1.14e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CA—malignant glioma	5.27e-06	1.14e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTEN—malignant glioma	4.6e-06	9.94e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—malignant glioma	4.31e-06	9.3e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CA—malignant glioma	3.25e-06	7.01e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—malignant glioma	2.65e-06	5.73e-06	CbGpPWpGaD
